Cargando…
Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
Muscle Invasive Bladder Cancer (MIBC) has a poor prognosis. Whilst patients can achieve a 6% improvement in overall survival with Neo-Adjuvant Chemotherapy (NAC), many do not respond. Body fluid mutant DNA (mutDNA) may allow non-invasive identification of treatment failure. We collected 248 liquid b...
Autores principales: | Patel, K. M., van der Vos, K. E., Smith, C. G., Mouliere, F., Tsui, D., Morris, J., Chandrananda, D., Marass, F., van den Broek, D., Neal, D. E., Gnanapragasam, V. J., Forshew, T., van Rhijn, B. W., Massie, C. E., Rosenfeld, N., van der Heijden, M. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514073/ https://www.ncbi.nlm.nih.gov/pubmed/28717136 http://dx.doi.org/10.1038/s41598-017-05623-3 |
Ejemplares similares
-
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
por: van der Vos, K. E., et al.
Publicado: (2020) -
Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
por: Mouliere, Florent, et al.
Publicado: (2018) -
Refined characterization of circulating tumor DNA through biological feature integration
por: Markus, Havell, et al.
Publicado: (2022) -
Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer
por: van Kessel, Kim E.M., et al.
Publicado: (2016) -
Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial
por: Stockem, C.F., et al.
Publicado: (2023)